Print

Virbac Corporation (VBAC) Exercises Its Options for a Commercial Licence Agreement to Use Vivalis' EBx(R) Platform  
4/1/2008 9:28:46 AM

NANTES, FRANCE--(Marketwire - April 01, 2008) - Highlighted Links VIRBAC EXERCISES ITS OPTION FOR A COMMERCIAL LICENCE AGREEMENT TO USE VIVALIS' EBx® PLATFORM FOR THE PRODUCTION OF SEVERAL VACCINES.
//-->